Editas medicine, inc. (EDIT)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Collaboration and other research and development revenues

24,185

20,531

14,366

25,037

30,079

31,937

29,485

21,248

16,973

13,728

10,959

5,639

5,930

6,053

5,825

5,030

0

-

0

0

-

Operating expenses:
Research and development

115,626

96,898

81,302

76,043

85,196

90,654

97,885

100,838

85,438

83,159

83,570

74,006

67,118

56,979

35,970

28,988

25,840

18,846

0

0

0

General and administrative

64,835

64,555

60,816

58,416

58,313

55,010

55,516

54,817

52,400

50,502

49,864

48,524

48,788

46,262

40,554

33,461

24,584

18,095

0

0

0

Total operating expenses

180,461

161,453

142,118

134,459

143,509

145,664

153,401

155,655

137,838

133,661

133,434

122,530

115,906

103,241

76,524

62,449

50,424

36,941

0

0

0

Operating loss

-156,276

-140,922

-127,752

-109,422

-113,430

-113,727

-123,916

-134,407

-120,865

-119,933

-122,475

-116,891

-109,976

-97,188

-70,577

-56,794

-47,990

-35,312

0

0

0

Other income, net:
Other income (expense), net

7,240

-137

-149

-120

102

328

461

661

629

587

423

230

113

-57

-248

-230

-37,376

-37,445

0

0

0

Interest income, net

6,815

7,313

6,871

6,215

5,064

3,445

2,366

1,296

70

-978

-1,459

-1,271

-672

62

385

199

12

-143

0

0

0

Total other income, net

14,055

7,176

6,722

6,095

5,166

3,773

2,827

1,957

699

-391

-1,036

-1,041

-559

5

137

-31

-37,364

-37,588

0

0

0

Net loss

-142,221

-133,746

-121,030

-103,327

-108,264

-109,954

-121,089

-132,450

-120,166

-120,324

-123,511

-117,932

-110,535

-97,183

-70,440

-56,825

-85,354

-72,900

0

0

0

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

-

-

-

-

47

146

250

346

394

0

0

0

Net loss attributable to common stockholders

-

-

-

-

-

0

-

-

-

-

-

-

-

-97,230

-70,586

-57,075

-85,700

-73,294

0

0

0

Net loss per share attributable to common stockholders, basic and diluted

-0.69

-0.73

-0.66

-0.69

-0.60

-0.52

-0.32

-0.82

-0.67

-0.84

-0.64

-0.65

-0.85

-1.09

-0.59

-0.54

-0.80

-1.78

-2.57

-21.45

-2.75

Weighted-average common shares outstanding, basic and diluted

54,590

52,204

49,820

49,070

48,838

48,032

47,414

46,952

45,992

42,671

41,307

40,830

36,485

35,805

35,505

35,286

22,280

3,162

2,925

2,222

1,957